CFGI Sentiment Reports · 15 quarters on record since 5 Jan 2023 · updated daily, as of 8 Sep 2026
AbbVie Quarterly Sentiment Reports
Every quarter of AbbVie (ABBV) sentiment since 5 Jan 2023, newest first. Each quarter lists its price performance, high, low and average, its sentiment high, low and average, its most volatile day for each, the chart of the whole quarter, the 10 sub-algorithm averages and a short summary. Q3 2026 is the running quarter: an average of 54 (Neutral).
AbbVie sentiment at a glance
- Quarters on record
- 15, since 5 Jan 2023
- Average sentiment, all closed quarters
- 51 of 100 (Neutral)
- Greediest quarter
- Q1 2024, average 63 (Greed)
- Most fearful quarter
- Q2 2023, average 39 (Fear)
- Best quarter for the ABBV price
- Q3 2025, +21.9%
- Worst quarter for the ABBV price
- Q2 2023, -16.0%
- Running quarter
- Q3 2026, average 54 (Neutral), ABBV price +0.3%
Updated daily; last reading . Every number is computed from CFGI's stored daily readings.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2026 | -5.2%47 | +17.1%52 | +0.3%54 | - |
| 2025 | +16.8%58 | -10.0%44 | +21.9%61 | -6.5%53 |
| 2024 | +13.9%63 | -5.1%44 | +15.9%59 | -9.8%46 |
| 2023 | -2.5%47 | -16.0%39 | +10.4%55 | +4.5%49 |
AbbVie Q3 2026 Sentiment Report
to In progress, updates daily| Performance | +0.3% | 1 Jul 2026 to 8 Sep 2026 |
|---|---|---|
| Price high | $265.97 | 19 Aug 2026 |
| Price low | $243.80 | 4 Aug 2026 |
| Average price | $254.55 | |
| Sentiment high | 79Greed | 2 Jul 2026 |
| Sentiment low | 24Fear | 4 Aug 2026 |
| Average sentiment | 54Neutral | |
| Most volatile day (price) | +4.2% | 16 Jul 2026 |
| Most volatile day (sentiment) | -29 points (65 to 36) | 31 Jul 2026 |
47 scored trading days of 50. Price is the ABBV price; performance is the first to the last scored day.
Q3 2026 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q3 2026, in its own band colour.
- Price58
- Volatility57
- Volume56
- Momentum53
- Technical61
- Social35
- Dominance51
- Trends45
- Whales53
- Orders48
Q3 2026 in brief
AbbVie is averaging 54 of 100 (Neutral) across 47 scored trading days in Q3 2026, opening at 74 on 1 Jul 2026 and reading 37 on 8 Sep 2026. Sentiment ran from 24 (Fear) on 4 Aug 2026 to 79 (Greed) on 2 Jul 2026. The ABBV price moved +0.3% from $251.06 to $251.90, with its biggest single-day move of +4.2% on 16 Jul 2026. The quarter is still open and updates daily.
AbbVie Q2 2026 Sentiment Report
to| Performance | +17.1% | 1 Apr 2026 to 30 Jun 2026 |
|---|---|---|
| Price high | $254.31 | 29 Jun 2026 |
| Price low | $197.38 | 27 Apr 2026 |
| Average price | $215.15 | |
| Sentiment high | 86Extreme Greed | 29 Jun 2026 |
| Sentiment low | 23Fear | 7 Apr 2026 |
| Average sentiment | 52Neutral | |
| Most volatile day (price) | +6.2% | 22 Jun 2026 |
| Most volatile day (sentiment) | +28 points (38 to 66) | 22 Jun 2026 |
62 scored trading days of 65. Price is the ABBV price; performance is the first to the last scored day.
Q2 2026 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q2 2026, in its own band colour.
- Price53
- Volatility55
- Volume54
- Momentum57
- Technical51
- Socialn/a
- Dominance23
- Trendsn/a
- Whales50
- Orders48
Q2 2026 in brief
AbbVie averaged 52 of 100 (Neutral) across 62 scored trading days in Q2 2026, opening at 57 on 1 Apr 2026 and closing at 83 on 30 Jun 2026. Sentiment ran from 23 (Fear) on 7 Apr 2026 to 86 (Extreme Greed) on 29 Jun 2026. The ABBV price moved +17.1% from $214.98 to $251.64, with its biggest single-day move of +6.2% on 22 Jun 2026.
AbbVie Q1 2026 Sentiment Report
to| Performance | -5.2% | 2 Jan 2026 to 31 Mar 2026 |
|---|---|---|
| Price high | $236.19 | 4 Mar 2026 |
| Price low | $204.93 | 23 Mar 2026 |
| Average price | $221.82 | |
| Sentiment high | 77Greed | 17 Feb 2026 |
| Sentiment low | 15Extreme Fear | 20 Mar 2026 |
| Average sentiment | 47Neutral | |
| Most volatile day (price) | -5.2% | 18 Mar 2026 |
| Most volatile day (sentiment) | +27 points (38 to 65) | 7 Jan 2026 |
61 scored trading days of 64. Price is the ABBV price; performance is the first to the last scored day.
Q1 2026 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q1 2026, in its own band colour.
- Price47
- Volatility46
- Volume48
- Momentum46
- Technical54
- Socialn/a
- Dominance37
- Trendsn/a
- Whales69
- Orders38
Q1 2026 in brief
AbbVie averaged 47 of 100 (Neutral) across 61 scored trading days in Q1 2026, opening at 57 on 2 Jan 2026 and closing at 61 on 31 Mar 2026. Sentiment ran from 15 (Extreme Fear) on 20 Mar 2026 to 77 (Greed) on 17 Feb 2026. The ABBV price moved -5.2% from $229.31 to $217.49, with its biggest single-day move of -5.2% on 18 Mar 2026.
AbbVie Q4 2025 Sentiment Report
to| Performance | -6.5% | 1 Oct 2025 to 31 Dec 2025 |
|---|---|---|
| Price high | $244.38 | 1 Oct 2025 |
| Price low | $211.96 | 3 Nov 2025 |
| Average price | $227.80 | |
| Sentiment high | 85Extreme Greed | 1 Oct 2025 |
| Sentiment low | 19Extreme Fear | 3 Nov 2025 |
| Average sentiment | 53Neutral | |
| Most volatile day (price) | -4.5% | 31 Oct 2025 |
| Most volatile day (sentiment) | -39 points (75 to 36) | 6 Oct 2025 |
64 scored trading days of 66. Price is the ABBV price; performance is the first to the last scored day.
Q4 2025 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q4 2025, in its own band colour.
- Price53
- Volatility51
- Volume51
- Momentum50
- Technical58
- Socialn/a
- Dominance42
- Trendsn/a
- Whales69
- Orders42
Q4 2025 in brief
AbbVie averaged 53 of 100 (Neutral) across 64 scored trading days in Q4 2025, opening at 85 on 1 Oct 2025 and closing at 57 on 31 Dec 2025. Sentiment ran from 19 (Extreme Fear) on 3 Nov 2025 to 85 (Extreme Greed) on 1 Oct 2025. The ABBV price moved -6.5% from $244.38 to $228.49, with its biggest single-day move of -4.5% on 31 Oct 2025.
AbbVie Q3 2025 Sentiment Report
to| Performance | +21.9% | 1 Jul 2025 to 30 Sep 2025 |
|---|---|---|
| Price high | $231.54 | 30 Sep 2025 |
| Price low | $184.85 | 21 Jul 2025 |
| Average price | $203.64 | |
| Sentiment high | 79Greed | 30 Sep 2025 |
| Sentiment low | 36Fear | 15 Jul 2025 |
| Average sentiment | 61Greed | |
| Most volatile day (price) | +4.1% | 11 Sep 2025 |
| Most volatile day (sentiment) | -25 points (61 to 36) | 15 Jul 2025 |
64 scored trading days of 66. Price is the ABBV price; performance is the first to the last scored day.
Q3 2025 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q3 2025, in its own band colour.
- Price63
- Volatility60
- Volume59
- Momentum61
- Technical65
- Socialn/a
- Dominance33
- Trendsn/a
- Whales57
- Orders62
Q3 2025 in brief
AbbVie averaged 61 of 100 (Greed) across 64 scored trading days in Q3 2025, opening at 63 on 1 Jul 2025 and closing at 79 on 30 Sep 2025. Sentiment ran from 36 (Fear) on 15 Jul 2025 to 79 (Greed) on 30 Sep 2025. The ABBV price moved +21.9% from $189.99 to $231.54, with its biggest single-day move of +4.1% on 11 Sep 2025.
AbbVie Q2 2025 Sentiment Report
to| Performance | -10.0% | 1 Apr 2025 to 30 Jun 2025 |
|---|---|---|
| Price high | $206.27 | 1 Apr 2025 |
| Price low | $170.16 | 21 Apr 2025 |
| Average price | $185.85 | |
| Sentiment high | 76Greed | 29 Apr 2025 |
| Sentiment low | 14Extreme Fear | 8 Apr 2025 |
| Average sentiment | 44Neutral | |
| Most volatile day (price) | -7.3% | 4 Apr 2025 |
| Most volatile day (sentiment) | +27 points (30 to 57) | 19 May 2025 |
62 scored trading days of 65. Price is the ABBV price; performance is the first to the last scored day.
Q2 2025 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q2 2025, in its own band colour.
- Price46
- Volatility48
- Volume47
- Momentum47
- Technical42
- Socialn/a
- Dominance39
- Trendsn/a
- Whales35
- Orders53
Q2 2025 in brief
AbbVie averaged 44 of 100 (Neutral) across 62 scored trading days in Q2 2025, opening at 61 on 1 Apr 2025 and closing at 43 on 30 Jun 2025. Sentiment ran from 14 (Extreme Fear) on 8 Apr 2025 to 76 (Greed) on 29 Apr 2025. The ABBV price moved -10.0% from $206.27 to $185.62, with its biggest single-day move of -7.3% on 4 Apr 2025.
AbbVie Q1 2025 Sentiment Report
to| Performance | +16.8% | 2 Jan 2025 to 31 Mar 2025 |
|---|---|---|
| Price high | $216.66 | 10 Mar 2025 |
| Price low | $169.20 | 22 Jan 2025 |
| Average price | $194.40 | |
| Sentiment high | 83Extreme Greed | 3 Mar 2025 |
| Sentiment low | 25Fear | 26 Mar 2025 |
| Average sentiment | 58Neutral | |
| Most volatile day (price) | +4.7% | 31 Jan 2025 |
| Most volatile day (sentiment) | +28 points (32 to 60) | 27 Jan 2025 |
60 scored trading days of 64. Price is the ABBV price; performance is the first to the last scored day.
Q1 2025 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q1 2025, in its own band colour.
- Price61
- Volatility59
- Volume56
- Momentum58
- Technical56
- Socialn/a
- Dominance42
- Trendsn/a
- Whales33
- Orders64
Q1 2025 in brief
AbbVie averaged 58 of 100 (Neutral) across 60 scored trading days in Q1 2025, opening at 52 on 2 Jan 2025 and closing at 68 on 31 Mar 2025. Sentiment ran from 25 (Fear) on 26 Mar 2025 to 83 (Extreme Greed) on 3 Mar 2025. The ABBV price moved +16.8% from $179.44 to $209.52, with its biggest single-day move of +4.7% on 31 Jan 2025.
AbbVie Q4 2024 Sentiment Report
to| Performance | -9.8% | 1 Oct 2024 to 31 Dec 2024 |
|---|---|---|
| Price high | $203.87 | 31 Oct 2024 |
| Price low | $164.99 | 15 Nov 2024 |
| Average price | $183.86 | |
| Sentiment high | 81Extreme Greed | 31 Oct 2024 |
| Sentiment low | 18Extreme Fear | 12 Nov 2024 |
| Average sentiment | 46Neutral | |
| Most volatile day (price) | -12.6% | 11 Nov 2024 |
| Most volatile day (sentiment) | -35 points (56 to 21) | 11 Nov 2024 |
64 scored trading days of 66. Price is the ABBV price; performance is the first to the last scored day.
Q4 2024 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q4 2024, in its own band colour.
- Price45
- Volatility45
- Volume48
- Momentum48
- Technical49
- Socialn/a
- Dominance30
- Trendsn/a
- Whales63
- Orders35
Q4 2024 in brief
AbbVie averaged 46 of 100 (Neutral) across 64 scored trading days in Q4 2024, opening at 66 on 1 Oct 2024 and closing at 44 on 31 Dec 2024. Sentiment ran from 18 (Extreme Fear) on 12 Nov 2024 to 81 (Extreme Greed) on 31 Oct 2024. The ABBV price moved -9.8% from $196.96 to $177.70, with its biggest single-day move of -12.6% on 11 Nov 2024.
AbbVie Q3 2024 Sentiment Report
to| Performance | +15.9% | 1 Jul 2024 to 30 Sep 2024 |
|---|---|---|
| Price high | $199.35 | 10 Sep 2024 |
| Price low | $163.84 | 3 Jul 2024 |
| Average price | $186.63 | |
| Sentiment high | 81Extreme Greed | 26 Jul 2024 |
| Sentiment low | 30Fear | 3 Jul 2024 |
| Average sentiment | 59Neutral | |
| Most volatile day (price) | +3.6% | 17 Jul 2024 |
| Most volatile day (sentiment) | -18 points (65 to 47) | 5 Sep 2024 |
64 scored trading days of 66. Price is the ABBV price; performance is the first to the last scored day.
Q3 2024 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q3 2024, in its own band colour.
- Price60
- Volatility58
- Volume55
- Momentum58
- Technical62
- Socialn/a
- Dominance44
- Trendsn/a
- Whales45
- Orders62
Q3 2024 in brief
AbbVie averaged 59 of 100 (Neutral) across 64 scored trading days in Q3 2024, opening at 52 on 1 Jul 2024 and closing at 64 on 30 Sep 2024. Sentiment ran from 30 (Fear) on 3 Jul 2024 to 81 (Extreme Greed) on 26 Jul 2024. The ABBV price moved +15.9% from $170.37 to $197.48, with its biggest single-day move of +3.6% on 17 Jul 2024.
AbbVie Q2 2024 Sentiment Report
to| Performance | -5.1% | 1 Apr 2024 to 28 Jun 2024 |
|---|---|---|
| Price high | $180.76 | 1 Apr 2024 |
| Price low | $154.79 | 29 May 2024 |
| Average price | $165.65 | |
| Sentiment high | 75Greed | 7 Jun 2024 |
| Sentiment low | 19Extreme Fear | 4 Apr 2024 |
| Average sentiment | 44Neutral | |
| Most volatile day (price) | -5.3% | 4 Apr 2024 |
| Most volatile day (sentiment) | +28 points (31 to 59) | 31 May 2024 |
63 scored trading days of 65. Price is the ABBV price; performance is the first to the last scored day.
Q2 2024 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q2 2024, in its own band colour.
- Price45
- Volatility47
- Volume48
- Momentum48
- Technical53
- Socialn/a
- Dominance29
- Trendsn/a
- Whales42
- Orders39
Q2 2024 in brief
AbbVie averaged 44 of 100 (Neutral) across 63 scored trading days in Q2 2024, opening at 60 on 1 Apr 2024 and closing at 58 on 28 Jun 2024. Sentiment ran from 19 (Extreme Fear) on 4 Apr 2024 to 75 (Greed) on 7 Jun 2024. The ABBV price moved -5.1% from $180.76 to $171.52, with its biggest single-day move of -5.3% on 4 Apr 2024.
AbbVie Q1 2024 Sentiment Report
to| Performance | +13.9% | 2 Jan 2024 to 28 Mar 2024 |
|---|---|---|
| Price high | $182.10 | 28 Mar 2024 |
| Price low | $159.82 | 2 Jan 2024 |
| Average price | $172.34 | |
| Sentiment high | 82Extreme Greed | 4 Jan 2024 |
| Sentiment low | 40Neutral | 20 Mar 2024 |
| Average sentiment | 63Greed | |
| Most volatile day (price) | -2.0% | 24 Jan 2024 |
| Most volatile day (sentiment) | -18 points (62 to 44) | 15 Mar 2024 |
61 scored trading days of 65. Price is the ABBV price; performance is the first to the last scored day.
Q1 2024 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q1 2024, in its own band colour.
- Price68
- Volatility57
- Volume55
- Momentum61
- Technical61
- Socialn/a
- Dominance46
- Trendsn/a
- Whales34
- Orders71
Q1 2024 in brief
AbbVie averaged 63 of 100 (Greed) across 61 scored trading days in Q1 2024, opening at 75 on 2 Jan 2024 and closing at 64 on 28 Mar 2024. Sentiment ran from 40 (Neutral) on 20 Mar 2024 to 82 (Extreme Greed) on 4 Jan 2024. The ABBV price moved +13.9% from $159.82 to $182.10, with its biggest single-day move of -2.0% on 24 Jan 2024.
AbbVie Q4 2023 Sentiment Report
to| Performance | +4.5% | 2 Oct 2023 to 29 Dec 2023 |
|---|---|---|
| Price high | $154.97 | 29 Dec 2023 |
| Price low | $137.60 | 15 Nov 2023 |
| Average price | $145.79 | |
| Sentiment high | 82Extreme Greed | 13 Dec 2023 |
| Sentiment low | 22Fear | 27 Oct 2023 |
| Average sentiment | 49Neutral | |
| Most volatile day (price) | -4.3% | 27 Oct 2023 |
| Most volatile day (sentiment) | +21 points (31 to 52) | 1 Nov 2023 |
63 scored trading days of 65. Price is the ABBV price; performance is the first to the last scored day.
Q4 2023 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q4 2023, in its own band colour.
- Price50
- Volatility52
- Volume50
- Momentum51
- Technical39
- Socialn/a
- Dominance34
- Trendsn/a
- Whales77
- Orders52
Q4 2023 in brief
AbbVie averaged 49 of 100 (Neutral) across 63 scored trading days in Q4 2023, opening at 29 on 2 Oct 2023 and closing at 66 on 29 Dec 2023. Sentiment ran from 22 (Fear) on 27 Oct 2023 to 82 (Extreme Greed) on 13 Dec 2023. The ABBV price moved +4.5% from $148.25 to $154.97, with its biggest single-day move of -4.3% on 27 Oct 2023.
AbbVie Q3 2023 Sentiment Report
to| Performance | +10.4% | 3 Jul 2023 to 29 Sep 2023 |
|---|---|---|
| Price high | $154.65 | 25 Sep 2023 |
| Price low | $133.59 | 13 Jul 2023 |
| Average price | $146.80 | |
| Sentiment high | 81Extreme Greed | 28 Jul 2023 |
| Sentiment low | 34Fear | 10 Jul 2023 |
| Average sentiment | 55Neutral | |
| Most volatile day (price) | +4.9% | 27 Jul 2023 |
| Most volatile day (sentiment) | +17 points (56 to 73) | 27 Jul 2023 |
63 scored trading days of 65. Price is the ABBV price; performance is the first to the last scored day.
Q3 2023 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q3 2023, in its own band colour.
- Price57
- Volatility56
- Volume55
- Momentum57
- Technical59
- Socialn/a
- Dominance33
- Trendsn/a
- Whales48
- Orders52
Q3 2023 in brief
AbbVie averaged 55 of 100 (Neutral) across 63 scored trading days in Q3 2023, opening at 46 on 3 Jul 2023 and closing at 34 on 29 Sep 2023. Sentiment ran from 34 (Fear) on 10 Jul 2023 to 81 (Extreme Greed) on 28 Jul 2023. The ABBV price moved +10.4% from $135.01 to $149.06, with its biggest single-day move of +4.9% on 27 Jul 2023.
AbbVie Q2 2023 Sentiment Report
to| Performance | -16.0% | 3 Apr 2023 to 30 Jun 2023 |
|---|---|---|
| Price high | $164.90 | 25 Apr 2023 |
| Price low | $132.51 | 28 Jun 2023 |
| Average price | $146.64 | |
| Sentiment high | 72Greed | 25 Apr 2023 |
| Sentiment low | 18Extreme Fear | 27 Apr 2023 |
| Average sentiment | 39Fear | |
| Most volatile day (price) | -8.0% | 27 Apr 2023 |
| Most volatile day (sentiment) | -39 points (57 to 18) | 27 Apr 2023 |
62 scored trading days of 65. Price is the ABBV price; performance is the first to the last scored day.
Q2 2023 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q2 2023, in its own band colour.
- Price42
- Volatility43
- Volume44
- Momentum43
- Technical42
- Socialn/a
- Dominance27
- Trendsn/a
- Whalesn/a
- Orders40
Q2 2023 in brief
AbbVie averaged 39 of 100 (Fear) across 62 scored trading days in Q2 2023, opening at 64 on 3 Apr 2023 and closing at 40 on 30 Jun 2023. Sentiment ran from 18 (Extreme Fear) on 27 Apr 2023 to 72 (Greed) on 25 Apr 2023. The ABBV price moved -16.0% from $160.42 to $134.73, with its biggest single-day move of -8.0% on 27 Apr 2023.
AbbVie Q1 2023 Sentiment Report
to| Performance | -2.5% | 5 Jan 2023 to 31 Mar 2023 |
|---|---|---|
| Price high | $166.55 | 6 Jan 2023 |
| Price low | $144.61 | 8 Feb 2023 |
| Average price | $152.55 | |
| Sentiment high | 76Greed | 5 Jan 2023 |
| Sentiment low | 10Extreme Fear | 12 Jan 2023 |
| Average sentiment | 47Neutral | |
| Most volatile day (price) | -3.1% | 12 Jan 2023 |
| Most volatile day (sentiment) | -31 points (74 to 43) | 9 Jan 2023 |
60 scored trading days of 65. Price is the ABBV price; performance is the first to the last scored day.
Q1 2023 sub-algorithms
Average of each of the 10 CFGI components over the scored trading days of Q1 2023, in its own band colour.
- Price47
- Volatility51
- Volume52
- Momentum51
- Technical54
- Socialn/a
- Dominance43
- Trendsn/a
- Whalesn/a
- Orders67
Q1 2023 in brief
AbbVie averaged 47 of 100 (Neutral) across 60 scored trading days in Q1 2023, opening at 76 on 5 Jan 2023 and closing at 61 on 31 Mar 2023. Sentiment ran from 10 (Extreme Fear) on 12 Jan 2023 to 76 (Greed) on 5 Jan 2023. The ABBV price moved -2.5% from $163.49 to $159.37, with its biggest single-day move of -3.1% on 12 Jan 2023.
How these reports are built
Each quarter is computed from CFGI's stored daily readings of the Fear and Greed Index: the last 1d reading of every UTC day in the window, its 10 components and the stored daily ABBV price. Averages are over scored trading days only. A running quarter updates with every data cycle; a closed quarter is final. Cite as: CFGI, AbbVie Quarterly Sentiment Reports, cfgi.io, 8 Sep 2026, https://cfgi.io/abbvie-stock-quarterly-report/.
Frequently asked questions
Where do these AbbVie quarterly reports come from?
What is the most volatile day?
How does a quarter get a Partial record tag?
Where are the monthly reports?
CFGI is a sentiment gauge, not financial advice. It does not predict price or tell users when to trade. These reports describe what the crowd did; they are a mirror of the crowd, not a forecast.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.